Viatris signals low to mid-single-digit growth in Greater China for 2027 while targeting $50M+ Pacira cost synergies by

Viatris Q3 2026 earnings: EPS beat, guidance raised, Pacira deal boosts 2027 outlook despite supply risks in Europe and China.